In this webinar, Dr. Jeffrey Crawford presents the U.S. Food and Drug Administration (FDA) approval process for biosimilars, including the step-wise, “totality of evidence” approach.
AMERICAN SOCIETY OF HEMATOLOGY
2021 L Street NW, Suite 900, Washington, DC 20036
Phone 202-776-0544 | Fax 202-776-0545
Copyright © 2016 by American Society of Hematology